Cargando…

Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection

PURPOSE: In metastatic colorectal cancer (mCRC) patients (pts), treatment strategies integrating liver resection with induction chemotherapy offer better 5-year survival rates than chemotherapy alone. However, liver resection is a complex and costly procedure, and recurrence occurs in almost 2/3rds...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costantini, Susan, Di Gennaro, Elena, Capone, Francesca, De Stefano, Alfonso, Nasti, Guglielmo, Vitagliano, Carlo, Setola, Sergio Venanzio, Tatangelo, Fabiana, Delrio, Paolo, Izzo, Francesco, Avallone, Antonio, Budillon, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875807/ https://www.ncbi.nlm.nih.gov/pubmed/36713567 http://dx.doi.org/10.3389/fonc.2022.1110104

Ejemplares similares

Potential Anticancer Effects of Polyphenols from Chestnut Shell Extracts: Modulation of Cell Growth, and Cytokinomic and Metabolomic Profiles
por: Sorice, Angela, et al.
Publicado: (2016)

Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line
por: Marchese, Silvia, et al.
Publicado: (2018)

The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes
por: Capone, Francesca, et al.
Publicado: (2015)

The safety and efficacy of Glubran 2 as biliostatic agent in liver resection
por: Patrone, Renato, et al.
Publicado: (2021)

Magnetic Resonance Features of Liver Mucinous Colorectal Metastases: What the Radiologist Should Know
por: Granata, Vincenza, et al.
Publicado: (2022)

EOB-MR Based Radiomics Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases
por: Granata, Vincenza, et al.
Publicado: (2022)

CytReD: A database collecting human cytokinome information
por: Miele, Marco, et al.
Publicado: (2011)

Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays
por: Capone, Francesca, et al.
Publicado: (2016)

Human Cytokinome: a new challenge for systems biology
por: Costantini, Susan, et al.
Publicado: (2010)

Evaluation of Selenite Effects on Selenoproteins and Cytokinome in Human Hepatoma Cell Lines
por: Rusolo, Fabiola, et al.
Publicado: (2013)

Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection
por: Costantini, Susan, et al.
Publicado: (2012)

Contrast MR-Based Radiomics and Machine Learning Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases: A Preliminary Study
por: Granata, Vincenza, et al.
Publicado: (2022)

Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial
por: Avallone, Antonio, et al.
Publicado: (2021)

Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders
por: Viardot-Foucault, Veronique, et al.
Publicado: (2023)

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Diagnostic performance of gadoxetic acid–enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection
por: Granata, Vincenza, et al.
Publicado: (2019)

Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective Analysis
por: Rega, Daniela, et al.
Publicado: (2022)

Sequential PET/CT with [(18)F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression Analysis
por: Pecori, Biagio, et al.
Publicado: (2017)

Major and Ancillary Features According to LI-RADS in the Assessment of Combined Hepatocellular-cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2020)

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol
por: Avallone, Antonio, et al.
Publicado: (2020)

Radiological assessment of secondary biliary tree lesions: an update
por: Granata, Vincenza, et al.
Publicado: (2020)

Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting
por: Granata, Vincenza, et al.
Publicado: (2020)

Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II study
por: Avallone, A, et al.
Publicado: (2006)

Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by Electrochemotherapy
por: Rega, Daniela, et al.
Publicado: (2021)

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
por: Cardone, C., et al.
Publicado: (2023)

Synthesis, Characterization, and In Vivo Cytokinome Profile of IL-12-Loaded PLGA Nanospheres
por: Lacinski, Ryan A., et al.
Publicado: (2022)

The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience
por: Denaro, Nerina, et al.
Publicado: (2022)

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)
por: Avallone, Antonio, et al.
Publicado: (2016)

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report
por: Petrillo, Mario, et al.
Publicado: (2015)

Evaluation of Tumor Response after Short-Course Radiotherapy and Delayed Surgery for Rectal Cancer
por: Rega, Daniela, et al.
Publicado: (2016)

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: results of the branch trial
por: Avallone, Antonio, et al.
Publicado: (2015)

Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis
por: Tatangelo, Fabiana, et al.
Publicado: (2018)

Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017)

Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer
por: Capone, Francesca, et al.
Publicado: (2020)

Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer †
por: Costantini, Susan, et al.
Publicado: (2021)

CT-Based Radiomics Analysis to Predict Histopathological Outcomes Following Liver Resection in Colorectal Liver Metastases
por: Granata, Vincenza, et al.
Publicado: (2022)

A Metabolomics-Based Screening Proposal for Colorectal Cancer
por: Troisi, Jacopo, et al.
Publicado: (2022)

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
por: Grumetti, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_use25mj2gvaua8af8hsnjmkd9l